Fiera Capital Corp

Position in NVS — Novartis AG

CIK 1505817 MONTREAL, A8

Position in NVS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$23,455,498

+$2,206,294 QoQ

Shares Held

149,665

+7.6% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#109

of 1,603 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 18% Shared 82% None 0%

Healthcare · as of Jun 30, 2026

Fiera Capital Corp holds $640,231,388 across 6 Drug Manufacturers - General names. NVS ranks #6 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,894,762	$481,212,704
2	LLY	ELI LILLY & Co	47,526	$57,004,114
3	MRK	Merck & Co., Inc.	223,353	$28,700,860
4	GILD	Gilead Sciences, Inc.	207,217	$26,179,795
5	AZN	Astrazeneca PLC	124,873	$23,678,417
6	NVS	Novartis AG This page	149,665	$23,455,498

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,455,498	149,665	+7.6%	Shares	Sole	2026-08-07
2026-03-31	$21,249,204	139,111	+11.9%	Shares	Sole	2026-05-12
2025-12-31	$17,146,477	124,367	+32.4%	Shares	Other	2026-02-11
2025-09-30	$12,046,096	93,934	+115.1%	Shares	Sole	2025-11-07
2025-06-30	$5,284,627	43,671	+1331.8%	Shares	Other	2025-08-08
2022-09-30	$231,830	3,050	0.0%	Shares	Sole	2022-11-03
2022-06-30	$257,816	3,050	+19.6%	Shares	Sole	2022-08-10
2022-03-31	$223,762	2,550	0.0%	Shares	Sole	2022-05-09
2021-12-31	$223,048	2,550	0.0%	Shares	Sole	2022-02-08
2021-09-30	$208,539	2,550	0.0%	Shares	Sole	2021-11-12
2021-06-30	$232,662	2,550	0.0%	Shares	Sole	2021-08-16
2021-03-31	$217,974	2,550	-99.4%	Shares	Sole	2021-05-11
2020-12-31	$39,948,893	423,053	-3.5%	Shares	Other	2021-02-09
2020-09-30	$38,119,785	438,360	-1.0%	Shares	Sole	2020-11-12
2020-06-30	$38,686,465	442,941	-28.2%	Shares	Other	2020-08-07
2020-03-31	$50,890,118	617,224	—	Shares	Other	2020-05-08
No filing history on record for this holder in this stock.